| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 25,928 | 30,149 | 30,419 | 39,842 | | Cost of Revenue | 9,545 | 12,719 | 13,944 | 23,086 | | | Gross Profit | 16,383 | 17,430 | 16,475 | 16,757 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,389 | 1,547 | 1,343 | 1,462 | | Non Recurring | 5,385 |
-
|
-
|
-
| | Others | 7,865 | 8,729 | 7,511 | 10,531 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,744 | 7,154 | 7,620 | 4,764 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,642 | 36 | 49 | 1,249 | | Earnings Before Interest And Taxes | 3,285 | 7,259 | 7,700 | 6,912 | | Interest Expense | 6,816 | 6,992 | 6,777 | 7,254 | | Income Before Tax | (3,531) | 267 | 924 | (342) | | Income Tax Expense | (81) | 13 | 38 | 391 | | Minority Interest | (341) |
-
|
-
| 270 | | | | Net Income From Continuing Ops | (3,276) | 305 | 886 | (734) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (1,261) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,616) | 305 | 886 | (1,994) | | Preferred Stock And Other Adjustments | 233 | (48) | (185) |
-
| | | Net Income Applicable To Common Shares | ($3,383) | $257 | $701 | ($1,994) |
|
0.37% Nasdaq 
Income Statement
